Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision identifier changes from v3.7.1 to v3.7.2. The study record itself remains unchanged.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a new revision entry for v3.7.0 in the study record history. The previous revision v3.6.6 was removed from the list.SummaryDifference0.0%

- Check50 days agoChange DetectedA new revision label v3.6.6 appears in the page footer, replacing the previous v3.6.5 in the history. This is a metadata update to the record history rather than substantive changes to the trial details.SummaryDifference0.0%

- Check71 days agoChange DetectedA new revision entry v3.6.5 has been added to the study record history, and the previous revision v3.6.4 was removed.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded the latest revision entry 'Revision: v3.6.4' to the Study Record History. This reflects an update to the page's version history.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.